You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國家財政部對華潤三九、恆瑞醫藥等19家醫藥企業作出行政處罰
阿思達克 04-12 15:52
國家財政部公布,依據會計法,對財政部有關監管局檢查的19家醫藥企業作出行政處罰。針對人民群眾長期反映的藥價虛高頑疾,財政部會同國家醫保局於2019年對77家醫藥企業實施會計信息質量檢查,檢查聚焦醫藥產品成本費用結構。檢查發現的其他違法違規問題,移交主管機關處理,涉及企業包括長白山製藥股份、江蘇恆瑞醫藥股份(600276.SH)、上海上藥新亞藥業、江蘇豪森藥業集團、華潤三九(000999.SZ)旗下深圳華潤三九醫藥貿易等。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account